Materials Today Nano · 2019 · 40 citations · 106 references
PharmacyImmunologyOncologyBiomaterialsCancer ImmunologyImmunotherapyCancer ImmunosurveillanceCancer ImmunotherapyLigand-mediated TargetingReceptor-mediated TargetingTargeted Cancer TherapyTumor Microenvironment ModulationBiomaterial-based ImmunomodulationImmune-modulatory BiomaterialsImmunomodulatory BiomaterialsTumor Targeting LigandsTumor-targeted Ligands
106
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun, Jiaxi Wu, Fenghe Du et al. · Science · 2012 · 4.8K citations
CpG motifs in bacterial DNA trigger direct B-cell activation
Arthur Μ. Krieg, Ae‐Kyung Yi, Sara Matson et al. · Nature · 1995 · 3.5K citations